Concepedia

Lijun Mu

LM

16

Publications

920

Citations

13

H-Index

2003

Active since

Affiliations

First Affiliated Hospital of Xi'an Jiaotong University(Current)

University of Oslo

Ministry of Education of the People's Republic of China

Norwegian Cancer Society

Second Affiliated Hospital of Dalian Medical University

Lijun Mu is an author at First Affiliated Hospital of Xi'an Jiaotong University specializing in medicine, cell biology, and radiation oncology.

ORCID

Top concepts

Publications per year

2003–2022

16

Publications

16

Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA

Jon Amund Kyte, Lijun Mu, Steinar Aamdal et al. · Cancer Gene Therapy · 2006 · 206 citations

, , +8

A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease

Chengxin Shi, Jianati Dawulieti, Feiyu Shi et al. · Science Advances · 2022 · 206 citations · Full text

Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients

Lijun Mu, Jon Amund Kyte, Gunnar Kvalheim et al. · British Journal of Cancer · 2005 · 113 citations · Full text

A Protocol for Generation of Clinical Grade mRNA‐Transfected Monocyte‐Derived Dendritic Cells for Cancer Vaccines

Lijun Mu, Gustav Gaudernack, Stein Sæbøe‐Larssen et al. · Scandinavian Journal of Immunology · 2003 · 66 citations · Full text

Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer

Bing Guan, Kaijie Wu, Jin Zeng et al. · Oncotarget · 2016 · 61 citations · Full text

, , +12

Rows per page

1–5 of 16